These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
596 related items for PubMed ID: 21497633
41. Retrospective: animal attacks and rabies exposures in Thai children. Sriaroon C, Sriaroon P, Daviratanasilpa S, Khawplod P, Wilde H. Travel Med Infect Dis; 2006 Sep; 4(5):270-4. PubMed ID: 16905457 [Abstract] [Full Text] [Related]
42. A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in China. Li R, Huang L, Li J, Mo Z, He B, Wang Y, Wu X, Minutello M, Guinet-Morlot F, Pichon S. Vaccine; 2013 Dec 05; 31(50):5940-7. PubMed ID: 24148575 [Abstract] [Full Text] [Related]
43. Risk factors for human rabies in China. Gong Z, He F, Chen Z. Zoonoses Public Health; 2012 Feb 05; 59(1):39-43. PubMed ID: 21824368 [Abstract] [Full Text] [Related]
44. Should travellers to rabies-endemic countries be pre-exposure vaccinated? An assessment of post-exposure prophylaxis and pre-exposure prophylaxis given to Danes travelling to rabies-endemic countries 2000-12. Christiansen AH, Rodriguez AB, Nielsen J, Cowan SA. J Travel Med; 2016 Apr 05; 23(4):. PubMed ID: 27147729 [Abstract] [Full Text] [Related]
45. Comparison of Theater Medical Data Store and Reportable Medical Event Records to Theater Animal Bite Reports Submissions, 2018-2019. Knobbe MG, Aden BJ, Ashbaugh HR. Mil Med; 2024 May 18; 189(5-6):e1166-e1173. PubMed ID: 37997678 [Abstract] [Full Text] [Related]
46. Safety and immunogenicity of chromatographically purified Vero cell rabies vaccine for intradermal pre- and post-exposure rabies prophylaxis. Tantawichien T, Sibunruang S, Tantawichien T, Angsanakul J, Benjavongkulchai M, Limsuwan K, Udomchaisakul P, Khomvilai S, Sitprija V. Expert Rev Vaccines; 2014 Dec 18; 13(12):1593-601. PubMed ID: 25315021 [Abstract] [Full Text] [Related]
47. Current rabies vaccines and prophylaxis schedules: preventing rabies before and after exposure. Warrell MJ. Travel Med Infect Dis; 2012 Jan 18; 10(1):1-15. PubMed ID: 22342356 [Abstract] [Full Text] [Related]
48. The Thai Red Cross protocol experience in Côte d'Ivoire. Tetchi M, Coulibaly M, Kallo V, Traoré GS, Issaka T, Joseph B, Gerber F, Lechenne M, Zinsstag J, Bonfoh B. Acta Trop; 2020 Dec 18; 212():105710. PubMed ID: 32941800 [Abstract] [Full Text] [Related]
49. Adverse events following rabies post-exposure prophylaxis: a comparative study of two different schedules and two vaccines. Sari T, Tulek N, Bulut C, Oral B, Tuncer Ertem G. Travel Med Infect Dis; 2014 Dec 18; 12(6 Pt A):659-66. PubMed ID: 24685372 [Abstract] [Full Text] [Related]
50. A multicentric community survey on animal exposures among humans in India. Ramesh Masthi NR, Pradeep BS, Bilagumba G. Indian J Public Health; 2019 Sep 18; 63(Supplement):S9-S14. PubMed ID: 31603085 [Abstract] [Full Text] [Related]
51. Antibody persistence, 32 years after post-exposure prophylaxis with human diploid cell rabies vaccine (HDCV). Fayaz A, Simani S, Janani A, Farahtaj F, Biglari P, Howeizi N, Eslami N. Vaccine; 2011 May 12; 29(21):3742-5. PubMed ID: 21458608 [Abstract] [Full Text] [Related]
52. Using serology to assist with complicated post-exposure prophylaxis for rabies and Australian bat lyssavirus. Conroy N, Vlack S, Williams JM, Patten JJ, Horvath RL, Lambert SB. PLoS Negl Trop Dis; 2013 May 12; 7(2):e2066. PubMed ID: 23469301 [Abstract] [Full Text] [Related]
54. Fatal rabies despite post-exposure prophylaxis. Deshmukh DG, Damle AS, Bajaj JK, Bhakre JB, Patil NS. Indian J Med Microbiol; 2011 May 12; 29(2):178-80. PubMed ID: 21654116 [Abstract] [Full Text] [Related]
55. A comparative study on the safety and immunogenicity of Purified duck embryo vaccine [corrected] (PDEV, Vaxirab) with purified chick embryo cell vaccine (PCEC, Rabipur) and purifed vero cell rabies vaccine (PVRV, Verorab). Ashwathnarayana DH, Madhusudana SN, Sampath G, Sathpathy DM, Mankeshwar R, Ravish HH, Ullas PT, Behra TR, Sudarshan MK, Gangaboraiah, Shamanna M. Vaccine; 2009 Dec 10; 28(1):148-51. PubMed ID: 19818720 [Abstract] [Full Text] [Related]
56. The need to improve access to rabies post-exposure vaccines: Lessons from Tanzania. Changalucha J, Steenson R, Grieve E, Cleaveland S, Lembo T, Lushasi K, Mchau G, Mtema Z, Sambo M, Nanai A, Govella NJ, Dilip A, Sikana L, Ventura F, Hampson K. Vaccine; 2019 Oct 03; 37 Suppl 1(Suppl 1):A45-A53. PubMed ID: 30309746 [Abstract] [Full Text] [Related]
57. Evaluation of state-provided postexposure prophylaxis against rabies in Florida. Conti L, Wiersma S, Hopkins R. South Med J; 2002 Feb 03; 95(2):225-30. PubMed ID: 11846250 [Abstract] [Full Text] [Related]
58. Should travellers in rabies endemic areas receive pre-exposure rabies immunization? Phanuphak P, Ubolyam S, Sirivichayakul S. Ann Med Interne (Paris); 1994 Feb 03; 145(6):409-11. PubMed ID: 7864502 [Abstract] [Full Text] [Related]
59. Epidemiology, clinical features and risk factors for human rabies and animal bites during an outbreak of rabies in Maputo and Matola cities, Mozambique, 2014: Implications for public health interventions for rabies control. Salomão C, Nacima A, Cuamba L, Gujral L, Amiel O, Baltazar C, Cliff J, Gudo ES. PLoS Negl Trop Dis; 2017 Jul 03; 11(7):e0005787. PubMed ID: 28742094 [Abstract] [Full Text] [Related]
60. Human rabies in Tianjin, China. Montgomery JP, Zhang Y, Wells EV, Liu Y, Clayton JL, Wang X, Boulton ML. J Public Health (Oxf); 2012 Dec 03; 34(4):505-11. PubMed ID: 22653884 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]